Skip to content

Frozen PRP administration for root bifurcation lesions

Safety evaluation of frozen PRP administration for root bifurcation lesions - Frozen PRP administration for root bifurcation lesions

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTc030230737
Enrollment
5
Registered
2024-03-27
Start date
2024-08-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Root bifurcation lesions Periodontal tissue regeneration

Interventions

Sponsors

Tobita Morikuni
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Bifurcation lesions and Lindhe and Nyman classification II degree or higher. 2) Basic periodontal treatment has been completed. 3) Subject teeth are less than 2 degrees of mobility and have keratinized gingiva that is considered appropriate for flap surgery. 4) Persons whose oral hygiene is established Good oral hygiene. 5) Have good systemic condition. 6) Number of platelet is over 1x10^5 /microli ter. 7) 18 years and older. 8) Other,the investigator believes makes him/her suitable for participation in the clinical study.

Exclusion criteria

Exclusion criteria: (1) Individuals for whom clinical attachment level measurement of the target tooth is not possible (2) Patients with current or past malignant tumors (3) Individuals with findings suggestive of malignancy, precancerous lesions, or suspected lesions during the pre-registration oral examination (4) Individuals with uncontrolled renal, hepatic, or hematologic disorders (5) Individuals who test positive for HCV antibodies, HBs antigen, ATLA virus antibodies, or HIV antibodies (6) Smokers (those who smoke an average of 10 or more cigarettes per day) (7) Individuals taking anticoagulants and whose blood condition is difficult to manage (8) Patients under the age of 18 (9) Women who wish to conceive, are pregnant or may be pregnant, or are breastfeeding (10) Others deemed inappropriate by the principal investigator due to serious infections or other reasons

Design outcomes

Primary

MeasureTime frame
Safety

Secondary

MeasureTime frame
Efficacy

Countries

Japan

Contacts

Public ContactMorikuni Tobita

untendo Hospital, Juntendo university school of medicine

mtobita@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026